mHealth-Bewegungsintervention für junge Krebsüberlebende (AYA-PACT)
Jugendliche und junge Erwachsene, die nach einer Krebsstudie körperlich aktiv werden
In this randomized controlled trial the investigators will determine whether a mobile health intervention can increase physical activity levels in AYA cancer survivors over a one year period. The investigators will recruit 320 cancer survivors in Alberta who were diagnosed with a first cancer between the ages of 15 to 39 years and are within one year of treatment completion. Participants will be randomized into either the control group (educational information) or the intervention group (educational information; personalized physical activity plan; activity tracker watch; access to a private, online survivor community; motivational text messages and check-in calls/e-mails). All participants will complete fitness testing and questionnaires at baseline, 6 months and 12 months. A final measurement at 24 months will test long-term effectiveness.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
Background:
There is a need for adolescent and young adult (AYA) cancer research because the number of new cancers in young people is increasing and the survivor population is growing. Interventions that try to reduce problems that affect people after cancer are particularly important since its treatments can have negative effects on survivors' physical and mental health even decades after diagnosis.
Aim:
Given the many positive effects of physical activity (e.g. improved fitness and quality of life), the study aims to encourage AYA cancer survivors to be more physically active as they shift from treatment to survivorship care. The main goal of this study is to see if a home-based, mobile health (mHealth) physical activity intervention can increase physical activity levels by at least 90 minutes/week compared to baseline in AYA cancer survivors.
Methods:
The investigators will conduct a two-center randomized controlled trial of 320 AYA cancer survivors. Participants (N=320) will be Albertan residents, diagnosed with a first cancer between the ages of 15 and 39 years, and within one year of cancer treatment completion. At the start of the study, participants will complete fitness testing and questionnaires. Participants will then be randomly put into either a control or intervention group. The control group will receive educational information only. The intervention group will also receive a personalized physical activity plan, an activity tracker watch, access to a private, online survivor community, motivational text messages and check-in calls/e-mails. Fitness testing and questionnaires will be repeated at 6 and 12 months to see if the intervention increased physical activity levels and improved health outcomes among the participants in the intervention group compared to controls. A final measurement at 24 months will test long-term use.
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Alberta
-
Calgary, Alberta, Kanada, T2N5G2
- Arthur J.E. Child Comprehensive Cancer Centre
-
Edmonton, Alberta, Kanada, T6G2H9
- University of Alberta
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Lives in Alberta
- Diagnosed with invasive malignancy in Alberta
- Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) in the last 12 months, except for "maintenance" therapy to prevent recurrences
- Have the ability to read, write and speak English
- Have access to the Internet on at least a weekly basis
- Have a mobile phone with a text messaging plan
- Willing to be randomized to either arm.
Exclusion Criteria:
- Health problems which preclude the ability to walk for physical activity, as measured by the Physical Activity Readiness Questionnaire (PAR-Q)
- Currently pregnant or planning to become pregnant within the next 6 months
- Currently taking part in > 300 minutes/week of moderate-to-vigorous intensity physical activity on a regular basis
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: mHealth Physical Activity Intervention
The intervention arm will receive a 12 month mobile health (mHealth) physical activity intervention with a goal of increasing their moderate-vigorous intensity physical activity levels by 90 minutes per week above baseline. |
The intervention includes a physical activity prescription, a Polar activity tracker watch, access to a private AYA cancer survivor community through the Polar Flow community platform, mHealth nudges and surveys via text messaging, and regular phone or email contact from study staff. |
|
Kein Eingriff: Control
Controls received "standard of care" from their medical team and were not provided with any physical activity guidance. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Changes in weekly minutes of moderate-vigorous intensity physical activity
Zeitfenster: Baseline to 12 months
|
Measured by ActiGraph |
Baseline to 12 months
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Changes in weekly minutes of moderate-vigorous intensity physical activity
Zeitfenster: Baseline to 6 months and 24 months.
|
Measured by ActiGraph |
Baseline to 6 months and 24 months.
|
|
Changes in weekly minutes of sleep
Zeitfenster: Baseline, 6 months, 12 months, 24 months
|
Measured by ActiGraph |
Baseline, 6 months, 12 months, 24 months
|
|
Changes in weekly minutes of sedentary time
Zeitfenster: Baseline, 6 months,12 months, 24 months
|
Measured by ActiGraph |
Baseline, 6 months,12 months, 24 months
|
|
Changes in moderate-vigorous physical activity using the self-administered Past Year Total Physical Activity Questionnaire (PYTPAQ).
Zeitfenster: Baseline, 12 months, 24 months.
|
Met-Hours per week and hours per week of moderate-vigorous physical activity |
Baseline, 12 months, 24 months.
|
|
Changes in the Pittsburgh Sleep Quality Index (PSQI) Global Sleep Quality Score
Zeitfenster: Baseline, 6 months,12 months
|
Global score range is 0 to 23 where higher scores indicate worse sleep quality |
Baseline, 6 months,12 months
|
|
Changes in weight
Zeitfenster: Baseline, 6 months,12 months
|
Measured in kilograms |
Baseline, 6 months,12 months
|
|
Changes in body mass index (BMI)
Zeitfenster: Baseline, 6 months,12 months
|
Measured by combining height (meters) and weight (kilograms) and reported in kg/m2 |
Baseline, 6 months,12 months
|
|
Changes in waist and hip circumference
Zeitfenster: Baseline, 6 months,12 months
|
Measured in centimeters |
Baseline, 6 months,12 months
|
|
Changes in cardiorespiratory fitness
Zeitfenster: Baseline, 6 months,12 months
|
Measured by peak oxygen consumption in relative (ml/kg/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation |
Baseline, 6 months,12 months
|
|
Changes in cardiorespiratory fitness
Zeitfenster: Baseline, 6 months,12 months
|
Measured by peak oxygen consumption in absolute (L/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation |
Baseline, 6 months,12 months
|
|
Changes in grip strength
Zeitfenster: Baseline, 6 months,12 months
|
Measured in kilograms using a hand dynamometer |
Baseline, 6 months,12 months
|
|
Changes in upper body muscular strength
Zeitfenster: Baseline, 6 months,12 months
|
Measured in kilograms using an 8-10 repetition maximum (RM) chest press test used to predict 1-RM |
Baseline, 6 months,12 months
|
|
Changes in upper body muscular endurance
Zeitfenster: Baseline, 6 months,12 months
|
Measured in kilograms using the maximum number of chest press repetitions completed at 50% of estimated 1-RM |
Baseline, 6 months,12 months
|
|
Changes in lower body muscular strength
Zeitfenster: Baseline, 6 months,12 months
|
Measured in kilograms using an 8-10 repetition maximum (RM) leg press test used to predict 1-RM |
Baseline, 6 months,12 months
|
|
Changes in lower body muscular endurance
Zeitfenster: Baseline, 6 months,12 months
|
Measured in kilograms using the maximum number of leg press repetitions completed at 70% of estimated 1-RM |
Baseline, 6 months,12 months
|
|
Changes in frailty
Zeitfenster: Baseline, 6 months,12 months
|
Defined according to the Fried phenotype which takes into account low lean muscle mass, exhaustion, low energy expenditure, walking limitations, and weakness |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Mental Health Component subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better mental health |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Physical Health Component subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better physical health |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Physical Functioning subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Role-physical subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Bodily Pain subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate less pain |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) General Health subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better health |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Vitality subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher vitality |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Social Functioning subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Role-emotional subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 Mental Health subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better mental health |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Impact of Cancer subscale
Zeitfenster: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Physical subscale
Zeitfenster: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Emotional subscale
Zeitfenster: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Cognitive subscale
Zeitfenster: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Cancer Worry subscale
Zeitfenster: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function Perceived Cognitive Impairment subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 72. Higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Comments From Others subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 16 where higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Perceived Cognitive Abilities subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 36 where higher scores indicate poorer cognition |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Impact on Quality of Life subscale
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 16 where higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Fatigue (FACT-F)
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 52 where higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Comprehensive Score for Financial Toxicity (COST)
Zeitfenster: Baseline, 6 months,12 months
|
Score range is from 0 to 44 where higher scores indicate better financial wellbeing |
Baseline, 6 months,12 months
|
|
Changes in fear of cancer recurrence - short form (FCRI-SF)
Zeitfenster: Baseline, 6 months, 12 months
|
Score range is from 0 - 36 where higher scores indicate greater fear of recurrence severity. |
Baseline, 6 months, 12 months
|
|
Changes in Sedentary Behaviour using a 7 day Sedentary Recall
Zeitfenster: Baseline, 6 months, 12 months.
|
Hours of sitting during the week and on weekends for the following categories: (1) traveling to work, (2) at work or school, (3) watching television, (4) using a computer, and (5) leisure time not including television. |
Baseline, 6 months, 12 months.
|
|
Changes in environmental barriers that prevent or limit walking and cycling where a person lives or works - PANES Questionnaire
Zeitfenster: Baseline, 6 months, 12 months.
|
Score range is from 1 to 4 with higher values indicating greater environmental support for physical activity. |
Baseline, 6 months, 12 months.
|
|
Changes in Exercise Self-Efficacy - Subscale (FITNET Questionnaire)
Zeitfenster: Baseline, 6 months, 12 months
|
Range of scores from 11 to 55 with higher scores indicated higher self-efficacy. |
Baseline, 6 months, 12 months
|
|
Changes in Social Support from Family and Friends related to Exercise - Subscale (FITNET Questionnaire)
Zeitfenster: Baseline, 6 months, 12 months.
|
Range of scores from 10 to 50 with higher scores indicating more support. |
Baseline, 6 months, 12 months.
|
|
Changes in Self-Monitoring related to setting exercise goals and planning exercise activities - Subscale (FITNET Questionnaire)
Zeitfenster: Baseline, 6 months, 12 months.
|
Range of scores from 12 to 60 with higher scores indicating more self-monitoring. |
Baseline, 6 months, 12 months.
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Mitarbeiter
Mitarbeiter
Ermittler
Ermittler
- Studienleiter: Miranda Fidler-Benaoudia, PhD, Cancer Care Alberta
- Hauptermittler: Christine Friedenreich, PhD, Cancer Care Alberta
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- HREBA.CC-20-0397
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .